Literature DB >> 7127903

Impaired antibody-dependent cell-mediated cytotoxicity in cryptogenic fibrosing alveolitis (synonym: idiopathic pulmonary fibrosis).

P L Haslam, F Allan, A F Watling, C Barrett, L Morris, M Turner-Warwick.   

Abstract

Mononuclear cells from the blood of 26 patients with the 'autoimmune' connective tissue disorder cryptogenic fibrosing alveolitis (CFA) were examined in Chang cell cytotoxicity assays for their capacity to mediate antibody-dependent cell-mediated cytotoxicity (ADCC). The results showed an impairment for the group by comparison with a group of 45 normal healthy controls (P less than 0.01). The impairment was greater in patients with associated connective tissue disorders of other systems (CFA+CT) than in those having the lung disorder alone (lone CFA); (P less than 0.001). The reduction in ADCC showed a correlation with reducing counts of cells bearing Fc gamma G surface receptors (P less than 0.05), and with increasing levels of soluble immune complexes in the blood of these patients by C1q binding (P=0.05). Non-specific esterase staining indicated that the Fc gamma G rosetting cells were subpopulations of lymphocytes not monocytes. We therefore suggest that the observed ADCC impairment may be due to impairment of lymphocyte Fc receptor function, and we speculate that this may influence immune regulation.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7127903      PMCID: PMC1536632     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  17 in total

1.  Circulating immune complexes in patients with cryptogenic fibrosing alveolitis.

Authors:  P L Haslam; B Thompson; I Mohammed; P J Townsend; M E Hodson; E J Holborow; M Turner-Warwick
Journal:  Clin Exp Immunol       Date:  1979-09       Impact factor: 4.330

2.  Competition for receptors for immunoglobulin on cytotoxic lymphocytes.

Authors:  I C MacLennan
Journal:  Clin Exp Immunol       Date:  1972-02       Impact factor: 4.330

3.  Assay of circulating immunoglobulins in patients with fibrosing alveolitis.

Authors:  J R Hobbs; M Turner-Warwick
Journal:  Clin Exp Immunol       Date:  1967-11       Impact factor: 4.330

4.  Cytochemical identification of monocytes and granulocytes.

Authors:  L T Yam; C Y Li; W H Crosby
Journal:  Am J Clin Pathol       Date:  1971-03       Impact factor: 2.493

5.  Bronchoalveolar lavage fluid cell counts in cryptogenic fibrosing alveolitis and their relation to therapy.

Authors:  P L Haslam; C W Turton; A Lukoszek; A J Salsbury; A Dewar; J V Collins; M Turner-Warwick
Journal:  Thorax       Date:  1980-05       Impact factor: 9.139

6.  Antibodies in some chronic fibrosing lung diseases. I. Non organ-specific autoantibodies.

Authors:  M Turner-Warwick; P Haslam
Journal:  Clin Allergy       Date:  1971-03

7.  Diffuse fibrosing alveolitis (diffuse interstitial fibrosis of the lungs). Correlation of histology at biopsy with prognosis.

Authors:  J G Scadding; K F Hinson
Journal:  Thorax       Date:  1967-07       Impact factor: 9.139

8.  Familial abnormalities of suppressor-cell function in systemic lupus erythematosus.

Authors:  K B Miller; R S Schwartz
Journal:  N Engl J Med       Date:  1979-10-11       Impact factor: 91.245

9.  Cryptogenic fibrosing alveolitis and lung cancer.

Authors:  M Turner-Warwick; M Lebowitz; B Burrows; A Johnson
Journal:  Thorax       Date:  1980-07       Impact factor: 9.139

10.  Cells, enzymes and interstitial lung disease. The Philip Ellman Lecture.

Authors:  M Turner-Warwick; P L Haslam; A Lukoszek; P Townsend; F Allan; R M Du Bois; C W Turton; J V Collins
Journal:  J R Coll Physicians Lond       Date:  1981-01
View more
  6 in total

Review 1.  Some connective tissue disorders of the lung.

Authors:  M Turner-Warwick
Journal:  Postgrad Med J       Date:  1988-07       Impact factor: 2.401

2.  Development of acute lung injury after the combination of intravenous bleomycin and exposure to hyperoxia in rats.

Authors:  J G Hay; P L Haslam; A Dewar; B Addis; M Turner-Warwick; G J Laurent
Journal:  Thorax       Date:  1987-05       Impact factor: 9.139

3.  Numerical and functional alterations in circulatory lymphocytes in cigarette smokers.

Authors:  D A Hughes; P L Haslam; P J Townsend; M Turner-Warwick
Journal:  Clin Exp Immunol       Date:  1985-08       Impact factor: 4.330

Review 4.  Complement system in lung disease.

Authors:  Pankita H Pandya; David S Wilkes
Journal:  Am J Respir Cell Mol Biol       Date:  2014-10       Impact factor: 6.914

5.  Pretreatment with lipoteichoic acid sensitizes target cells to antibody-dependent cellular cytotoxicity in the presence of anti-lipoteichoic acid antibodies.

Authors:  D E Lopatin; R E Kessler
Journal:  Infect Immun       Date:  1985-06       Impact factor: 3.441

6.  Label-free plasma proteomics identifies haptoglobin-related protein as candidate marker of idiopathic pulmonary fibrosis and dysregulation of complement and oxidative pathways.

Authors:  Mayank Saraswat; Sakari Joenväärä; Tiialotta Tohmola; Eva Sutinen; Ville Vartiainen; Katri Koli; Marjukka Myllärniemi; Risto Renkonen
Journal:  Sci Rep       Date:  2020-05-08       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.